Carrie Cox
Chairman bei ORGANON & CO.
Vermögen: 11 Mio $ am 31.03.2024
Profil
Frau Carrie S. Cox ist Vorstandsvorsitzende bei Organon & Co, Vorstandsvorsitzende bei Advantagene, Inc, Vorstandsvorsitzende bei Selecta Biosciences, Inc, unabhängiges Mitglied des Verwaltungsrats bei Cardinal Health, Inc, unabhängiges Mitglied des Verwaltungsrats bei Texas Instruments Incorporated und Mitglied des Beirats des University of Pennsylvania Museum of Archaeology & Anthropolog. Sie ist Mitglied des Board of Directors bei Cardinal Health, Inc. und Texas Instruments Incorporated. Frau Cox war zuvor als Vorsitzende bei Array BioPharma, Inc. tätig, als Vorsitzende bei electroCore, Inc., als unabhängige Direktorin bei Celgene Corp., als President-Global Pharmaceuticals & Executive VP bei Schering-Plough Corp., als Senior Vice President-Global Business Management bei Pharmacia & Upjohn, Inc, President-Global Prescription Business & EVP bei Pharmacia Corp., Mitglied bei der Harvard T.H. Chan School of Public Health, Principal bei Novartis Corp., Chairman bei Prism Pharmaceuticals, Inc. und Vice President-Women's Healthcare bei Wyeth-Ayerst Research. Außerdem war sie Vorstandsmitglied bei Humacyte, Inc. und Renetx Bio, Inc. Sie erhielt ihren Bachelor-Abschluss am Massachusetts College of Pharmacy & Health Science.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
28.02.2024 | 35 801 ( 0,00% ) | 6 Mio $ | 31.03.2024 | |
CARDINAL HEALTH, INC.
0,02% | 18.09.2023 | 41 631 ( 0,02% ) | 5 Mio $ | 31.03.2024 |
0,13% | 15.01.2024 | 212 881 ( 0,13% ) | 138 373 $ | 31.03.2024 |
ORGANON & CO.
-.--% | 09.06.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Carrie Cox
Unternehmen | Position | Beginn |
---|---|---|
TEXAS INSTRUMENTS INCORPORATED | Director/Board Member | 16.09.2004 |
ORGANON & CO. | Chairman | 02.06.2021 |
University of Pennsylvania Museum of Archaeology & Anthropolog | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Carrie Cox
Unternehmen | Position | Ende |
---|---|---|
CARDINAL HEALTH, INC. | Director/Board Member | 15.11.2023 |
HUMACYTE, INC. | Chief Executive Officer | 01.06.2018 |
CANDEL THERAPEUTICS, INC. | Chairman | 15.07.2021 |
ELECTROCORE, INC. | Chairman | 31.03.2020 |
CELGENE | Director/Board Member | 01.11.2019 |
Ausbildung von Carrie Cox
Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 6 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
TEXAS INSTRUMENTS INCORPORATED | Electronic Technology |
ELECTROCORE, INC. | Health Technology |
CANDEL THERAPEUTICS, INC. | Health Technology |
ORGANON & CO. | Health Technology |
HUMACYTE, INC. | Health Technology |
Private Unternehmen | 12 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Pharmacia & Upjohn, Inc. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Array BioPharma, Inc.
Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Prism Pharmaceuticals, Inc.
Prism Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prism Pharmaceuticals, Inc. manufactures cardiovascular injectables and pharmaceutical products. The firm engages in developing and commercializing branded cardiovascular injectable products which include NEXTERONE. The company was founded by Gilbert R. Gonzales and Cameron Durrant in 2003 and is headquartered in King of Prussia, PA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Humacyte Global, Inc.
Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
Selecta Biosciences, Inc.
Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Wyeth-Ayerst Research | |
University of Pennsylvania Museum of Archaeology & Anthropolog |